Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
12 studies found for:    Northwestern AND Amyotrophic Lateral Sclerosis
Show Display Options
Rank Status Study
1 Recruiting Genetics of Familial and Sporadic ALS
Conditions: Amyotrophic Lateral Sclerosis (ALS);   Familial Amyotrophic Lateral Sclerosis;   Amyotrophic Lateral Sclerosis With Frontotemporal Dementia;   Lou Gehrig's Disease;   Motor Neuron Disease;   Primary Lateral Sclerosis
Intervention: Other: Genetic study of ALS families
2 Active, not recruiting Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Genetic: VM202
3 Terminated Phase 3 Extension Study of Dexpramipexole in ALS
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: Dexpramipexole
4 Completed Phase 3 Study of Dexpramipexole in ALS
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Dexpramipexole;   Drug: Placebo
5 Completed
Has Results
Clinical Trial Ceftriaxone in Subjects With ALS
Conditions: Amyotrophic Lateral Sclerosis;   ALS
Interventions: Drug: ceftriaxone;   Other: placebo
6 Active, not recruiting Humanitarian Device Exemption Post-Approval Study of NeuRx Diaphragm Pacing System for Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Device: NeuRx Diaphragm Pacing System (DPS)
7 Completed
Has Results
Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS
Condition: Pseudobulbar Affect (PBA)
Interventions: Drug: dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg;   Drug: dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg;   Drug: Placebo
8 Completed Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: AVP-923
9 Withdrawn A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Placebo;   Drug: Arimoclomol
10 Active, not recruiting Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: tirasemtiv;   Drug: Placebo tablets
11 Completed
Has Results
Clinical Trial of High Dose CoQ10 in ALS
Conditions: Amyotrophic Lateral Sclerosis;   Lou Gehrig's Disease
Interventions: Drug: coenzyme Q10;   Drug: Placebo
12 Recruiting Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
Conditions: FTLD;   Progressive Supranuclear Palsy (PSP);   Frontotemporal Dementia (FTD);   Corticobasal Degeneration (CBD);   PPA Syndrome;   Behavioral Variant Frontotemporal Dementia (bvFTD);   Semantic Variant Primary Progressive Aphasia (svPPA);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   FTD With Amyotrophic Lateral Sclerosis (FTD/ALS);   Amyotrophic Lateral Sclerosis (ALS);   Oligosymptomatic PSP (oPSP);   Corticobasal Syndrome (CBS)
Intervention:

Study has passed its completion date and status has not been verified in more than two years.